Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Calendar
prev August 2020
Mon Tue Wed Thu Fri Sat Sun
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31
The common take-away was that «to become nature lovers, people need to have access to nature». Thus, the number one task is to create a legislative framework, currently all but non-existent. More Topics Interros / Sustainable tourism / ecotourism / nature tourism / Rosa Khutor
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
01.04.2020
Previously, in the role of the Senior Vice President, he was in charge of sales, procurement, and innovation at MMC Norilsk Nickel.
More Topics Interros
03.12.2018
The first place in the nomination «Medicine of choice for the treatment and prevention of SARS and influenza among children» was granted to «Polyoxidonium», produced by NGO Petrovax Pharm.
More Topics Petrovax Pharm
06.08.2018
In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.
More Topics Petrovax Pharm